Search Results - "Roque, Jonasel"

A single-cell atlas of the peripheral immune response in patients with severe COVID-19 by Wilk, Aaron J., Rustagi, Arjun, Zhao, Nancy Q., Roque, Jonasel, Martínez-Colón, Giovanny J., McKechnie, Julia L., Ivison, Geoffrey T., Ranganath, Thanmayi, Vergara, Rosemary, Hollis, Taylor, Simpson, Laura J., Grant, Philip, Subramanian, Aruna, Rogers, Angela J., Blish, Catherine A.

“…There is an urgent need to better understand the pathophysiology of Coronavirus disease 2019 (COVID-19), the global pandemic caused by SARS-CoV-2, which has…”
Get full text

A generalizable 29-mRNA neural-network classifier for acute bacterial and viral infections by Mayhew, Michael B., Buturovic, Ljubomir, Luethy, Roland, Midic, Uros, Moore, Andrew R., Roque, Jonasel A., Shaller, Brian D., Asuni, Tola, Rawling, David, Remmel, Melissa, Choi, Kirindi, Wacker, James, Khatri, Purvesh, Rogers, Angela J., Sweeney, Timothy E.

“…Improved identification of bacterial and viral infections would reduce morbidity from sepsis, reduce antibiotic overuse, and lower healthcare costs. Here, we…”
Get full text

Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis by Wilson, Jennifer G, Simpson, Laura J, Ferreira, Anne-Maud, Rustagi, Arjun, Roque, Jonasel, Asuni, Adijat, Ranganath, Thanmayi, Grant, Philip M, Subramanian, Aruna, Rosenberg-Hasson, Yael, Maecker, Holden T, Holmes, Susan P, Levitt, Joseph E, Blish, Catherine A, Rogers, Angela J

“…BACKGROUNDElevated levels of inflammatory cytokines have been associated with poor outcomes among COVID-19 patients. It is unknown, however, how these levels…”
Get full text

Prospective validation of an 11-gene mRNA host response score for mortality risk stratification in the intensive care unit by Moore, Andrew R., Roque, Jonasel, Shaller, Brian T., Asuni, Tola, Remmel, Melissa, Rawling, David, Liesenfeld, Oliver, Khatri, Purvesh, Wilson, Jennifer G., Levitt, Joseph E., Sweeney, Timothy E., Rogers, Angela J.

“…Several clinical calculators predict intensive care unit (ICU) mortality, however these are cumbersome and often require 24 h of data to calculate…”
Get full text

Deconvoluting complex correlates of COVID-19 severity with a multi-omic pandemic tracking strategy by Parikh, Victoria N., Ioannidis, Alexander G., Jimenez-Morales, David, Gorzynski, John E., De Jong, Hannah N., Liu, Xiran, Roque, Jonasel, Cepeda-Espinoza, Victoria P., Osoegawa, Kazutoyo, Hughes, Chris, Sutton, Shirley C., Youlton, Nathan, Joshi, Ruchi, Amar, David, Tanigawa, Yosuke, Russo, Douglas, Wong, Justin, Lauzon, Jessie T., Edelson, Jacob, Mas Montserrat, Daniel, Kwon, Yongchan, Rubinacci, Simone, Delaneau, Olivier, Cappello, Lorenzo, Kim, Jaehee, Shoura, Massa J., Raja, Archana N., Watson, Nathaniel, Hammond, Nathan, Spiteri, Elizabeth, Mallempati, Kalyan C., Montero-Martín, Gonzalo, Christle, Jeffrey, Kim, Jennifer, Kirillova, Anna, Seo, Kinya, Huang, Yong, Zhao, Chunli, Moreno-Grau, Sonia, Hershman, Steven G., Dalton, Karen P., Zhen, Jimmy, Kamm, Jack, Bhatt, Karan D., Isakova, Alina, Morri, Maurizio, Ranganath, Thanmayi, Blish, Catherine A., Rogers, Angela J., Nadeau, Kari, Yang, Samuel, Blomkalns, Andra, O’Hara, Ruth, Neff, Norma F., DeBoever, Christopher, Szalma, Sándor, Wheeler, Matthew T., Gates, Christian M., Farh, Kyle, Schroth, Gary P., Febbo, Phil, deSouza, Francis, Cornejo, Omar E., Fernandez-Vina, Marcelo, Kistler, Amy, Palacios, Julia A., Pinsky, Benjamin A., Bustamante, Carlos D., Rivas, Manuel A., Ashley, Euan A.

“…The SARS-CoV-2 pandemic has differentially impacted populations across race and ethnicity. A multi-omic approach represents a powerful tool to examine risk…”
Get full text

Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness by Feng, Allan, Yang, Emily Y, Moore, Andrew Reese, Dhingra, Shaurya, Chang, Sarah Esther, Yin, Xihui, Pi, Ruoxi, Mack, Elisabeth Km, Völkel, Sara, Geßner, Reinhard, Gündisch, Margrit, Neubauer, Andreas, Renz, Harald, Tsiodras, Sotirios, Fragkou, Paraskevi C, Asuni, Adijat A, Levitt, Joseph E, Wilson, Jennifer G, Leong, Michelle, Lumb, Jennifer H, Mao, Rong, Pinedo, Kassandra, Roque, Jonasel, Richards, Christopher M, Stabile, Mikayla, Swaminathan, Gayathri, Salagianni, Maria L, Triantafyllia, Vasiliki, Bertrams, Wilhelm, Blish, Catherine A, Carette, Jan E, Frankovich, Jennifer, Meffre, Eric, Nadeau, Kari Christine, Singh, Upinder, Wang, Taia T, Luning Prak, Eline T, Herold, Susanne, Andreakos, Evangelos, Schmeck, Bernd, Skevaki, Chrysanthi, Rogers, Angela J, Utz, Paul J

“…The widespread presence of autoantibodies in acute infection with SARS-CoV-2 is increasingly recognized, but the prevalence of autoantibodies in non-SARS-CoV-2…”
Get full text

Association between emergency department disposition and mortality in patients with COVID‐19 acute respiratory distress syndrome by Lebold, Katie M., Moore, Andrew R., Sanchez, Pablo A., Pacheco‐Navarro, Ana E., O'Donnell, Christian, Roque, Jonasel, Parmer, Caitlin, Pienkos, Shaun, Levitt, Joseph, Collins, William J., Rogers, Angela J., Wilson, Jennifer G.

“…Objectives Patients hospitalized for COVID‐19 frequently develop hypoxemia and acute respiratory distress syndrome (ARDS) after admission. In non‐COVID‐19 ARDS…”
Get full text

Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022 by Surie, Diya, Bonnell, Levi, Adams, Katherine, Gaglani, Manjusha, Ginde, Adit A, Douin, David J, Talbot, H Keipp, Casey, Jonathan D, Mohr, Nicholas M, Zepeski, Anne, McNeal, Tresa, Ghamande, Shekhar, Gibbs, Kevin W, Files, D Clark, Hager, David N, Shehu, Arber, Frosch, Anne P, Erickson, Heidi L, Gong, Michelle N, Mohamed, Amira, Johnson, Nicholas J, Srinivasan, Vasisht, Steingrub, Jay S, Peltan, Ithan D, Brown, Samuel M, Martin, Emily T, Khan, Akram, Bender, William S, Duggal, Abhijit, Wilson, Jennifer G, Qadir, Nida, Chang, Steven Y, Mallow, Christopher, Rivas, Carolina, Kwon, Jennie H, Exline, Matthew C, Lauring, Adam S, Shapiro, Nathan I, Halasa, Natasha, Chappell, James D, Grijalva, Carlos G, Rice, Todd W, Stubblefield, William B, Baughman, Adrienne, Womack, Kelsey N, Hart, Kimberly W, Swan, Sydney A, Zhu, Yuwei, DeCuir, Jennifer, Tenforde, Mark W, Patel, Manish M, McMorrow, Meredith L, Self, Wesley H

“…The SARS-CoV-2 Omicron variant (B.1.1.529 or BA.1) became predominant in the United States by late December 2021 (1). BA.1 has since been replaced by emerging…”
Get full text

Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial by Self, Wesley H, Semler, Matthew W, Leither, Lindsay M, Casey, Jonathan D, Angus, Derek C, Brower, Roy G, Chang, Steven Y, Collins, Sean P, Eppensteiner, John C, Filbin, Michael R, Files, D. Clark, Gibbs, Kevin W, Ginde, Adit A, Gong, Michelle N, Harrell, Frank E, Hayden, Douglas L, Hough, Catherine L, Johnson, Nicholas J, Khan, Akram, Lindsell, Christopher J, Matthay, Michael A, Moss, Marc, Park, Pauline K, Rice, Todd W, Robinson, Bryce R. H, Schoenfeld, David A, Shapiro, Nathan I, Steingrub, Jay S, Ulysse, Christine A, Weissman, Alexandra, Yealy, Donald M, Thompson, B. Taylor, Brown, Samuel M

“…IMPORTANCE: Data on the efficacy of hydroxychloroquine for the treatment of coronavirus disease 2019 (COVID-19) are needed. OBJECTIVE: To determine whether…”
Get full text

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial by Vock, David M., Vekstein, Andrew, Der, Tatyana, Filbin, Michael R., Rice, Todd W., Casey, Jonathan D., Sharifpour, Milad, Bakowska, Elizieta, Kowalska, Justyna, Hite, R. Duncan, Jain, Mamta K., Grandits, Greg, Polizzotto, Mark N., Jundgren, Jens D., Smolskis, Mary C., Voge, Susan E., McNay, Laura A., Cahill, Kelly, Kirchoff, Matthew, Mock, Rebecca, Zuckerman, Judith, Amos, Laura, Carter, Anita, Thompson, Greg, Marks, Mary E., Want, Samantha, Clariday, Laura, Fisher, Tammy, Palacious, Adriana, Whitacre, Heather, Bouffler, Andrew, Pappers, Brian, Preamble, Katarina, Bartolo, Elizabeth Berry, Baio, Kim T., Maton, Missy, Hutcheon, Douglass, Sher, Linda, Sharma, Aniket, Rodina, Valentina, Kadl, Alexandra, Fox, Ashley, Nossaman, Bobby, Laudun, Sylvia, Broussard, Shane, Rabin, Joseph, Saharia, Kapil, Shipman, Samantha, Parr, Doug, Bokhart, Gordon, Eichman, Sharon M., Ringwood, Nancy, Kardos, Cynthia, Talmor, Daniel, Banner-Goodspeed, Valerie, Peacock, Rebekah K., Yee, Kimberly J., Garcia, Rebekah L., Perez, Cynthia, McSparron, Jake I., Co, Ivan N., Wiedemann, Herbert P., More, Harshada, Roads, Tammy, Miller, Chadwick, Dhar, Sanjay, Johnson, Jakea, Gray, Christopher, Hays, Margaret, Vjecha, Michael, Petersen, Tianna, Gonzales, Sonia, Jibrell, Hodan, Klaphake, Jonathan, Vasudeva, Shikha, Hovmand, Nichlas, Kamstrup, Thobias, Bergsøe, Christina Marisa, Østergaard, Lars, Hertz, Mathias A., Lindnér, Cecilia Ebba Clara Ellinor, Havmøller, Signe Ravn, Exposito, Maria, Grüttner-Durmaz, Manuela, Horban, Andrzej, Virachit, Sophie, Ongko, Juwinda, Parmar, Mahesh KB, Kiweewa, Francis, Osinusi, Anu, Willis, Angela, Yan, Li, Bielica, Mona, Frye, Leanna, Galcik, Michael, Proffitt, Calvin, Smith, Kenneth, Murphy, Joseph, Flosi, Adam, Wenner, Christine

“…We aimed to assess the efficacy and safety of two neutralising monoclonal antibody therapies (sotrovimab [Vir Biotechnology and GlaxoSmithKline] and BRII-196…”
Get full text

Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19 by Wilk, Aaron J, Lee, Madeline J, Wei, Bei, Parks, Benjamin, Pi, Ruoxi, Martínez-Colón, Giovanny J, Ranganath, Thanmayi, Zhao, Nancy Q, Taylor, Shalina, Becker, Winston, Jimenez-Morales, David, Blomkalns, Andra L, O'Hara, Ruth, Ashley, Euan A, Nadeau, Kari C, Yang, Samuel, Holmes, Susan, Rabinovitch, Marlene, Rogers, Angela J, Greenleaf, William J, Blish, Catherine A

“…Our understanding of protective versus pathological immune responses to SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is limited by…”
Get full text

Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study by Adams, Katherine, Rhoads, Jillian P, Surie, Diya, Gaglani, Manjusha, Ginde, Adit A, McNeal, Tresa, Talbot, H Keipp, Casey, Jonathan D, Zepeski, Anne, Shapiro, Nathan I, Gibbs, Kevin W, Files, D Clark, Hager, David N, Frosch, Anne E, Exline, Matthew C, Mohamed, Amira, Johnson, Nicholas J, Steingrub, Jay S, Peltan, Ithan D, Brown, Samuel M, Martin, Emily T, Lauring, Adam S, Khan, Akram, Busse, Laurence W, Duggal, Abhijit, Wilson, Jennifer G, Chang, Steven Y, Mallow, Christopher, Kwon, Jennie H, Chappell, James D, Halasa, Natasha, Grijalva, Carlos G, Lindsell, Christopher J, Lester, Sandra N, Thornburg, Natalie J, Park, SoHee, McMorrow, Meredith L, Patel, Manish M, Tenforde, Mark W, Self, Wesley H

“…To compare the effectiveness of a primary covid-19 vaccine series plus booster doses with a primary series alone for the prevention of hospital admission with…”
Get more information

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19 by Ram-Mohan, Nikhil, Kim, David, Zudock, Elizabeth J, Hashemi, Marjan M, Tjandra, Kristel C, Rogers, Angela J, Blish, Catherine A, Nadeau, Kari C, Newberry, Jennifer A, Quinn, James V, O’Hara, Ruth, Ashley, Euan, Nguyen, Hien, Jiang, Lingxia, Hung, Paul, Blomkalns, Andra L, Yang, Samuel

“…Abstract Background The determinants of coronavirus disease 2019 (COVID-19) disease severity and extrapulmonary complications (EPCs) are poorly understood. We…”
Get full text

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021 by Self, Wesley H, Tenforde, Mark W, Rhoads, Jillian P, Gaglani, Manjusha, Ginde, Adit A, Douin, David J, Olson, Samantha M, Talbot, H Keipp, Casey, Jonathan D, Mohr, Nicholas M, Zepeski, Anne, McNeal, Tresa, Ghamande, Shekhar, Gibbs, Kevin W, Files, D Clark, Hager, David N, Shehu, Arber, Prekker, Matthew E, Erickson, Heidi L, Gong, Michelle N, Mohamed, Amira, Henning, Daniel J, Steingrub, Jay S, Peltan, Ithan D, Brown, Samuel M, Martin, Emily T, Monto, Arnold S, Khan, Akram, Hough, Catherine L, Busse, Laurence W, Ten Lohuis, Caitlin C, Duggal, Abhijit, Wilson, Jennifer G, Gordon, Alexandra June, Qadir, Nida, Chang, Steven Y, Mallow, Christopher, Rivas, Carolina, Babcock, Hilary M, Kwon, Jennie H, Exline, Matthew C, Halasa, Natasha, Chappell, James D, Lauring, Adam S, Grijalva, Carlos G, Rice, Todd W, Jones, Ian D, Stubblefield, William B, Baughman, Adrienne, Womack, Kelsey N, Lindsell, Christopher J, Hart, Kimberly W, Zhu, Yuwei, Mills, Lisa, Lester, Sandra N, Stumpf, Megan M, Naioti, Eric A, Kobayashi, Miwako, Verani, Jennifer R, Thornburg, Natalie J, Patel, Manish M

“…Three COVID-19 vaccines are authorized or approved for use among adults in the United States (1,2). Two 2-dose mRNA vaccines, mRNA-1273 from Moderna and…”
Get full text

Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study by Ozonoff, Al, Jayavelu, Naresh Doni, Liu, Shanshan, Melamed, Esther, Milliren, Carly E., Qi, Jingjing, Geng, Linda N., McComsey, Grace A., Cairns, Charles B., Baden, Lindsey R., Schaenman, Joanna, Shaw, Albert C., Samaha, Hady, Seyfert-Margolis, Vicki, Krammer, Florian, Rosen, Lindsey B., Steen, Hanno, Syphurs, Caitlin, Dandekar, Ravi, Shannon, Casey P., Sekaly, Rafick P., Ehrlich, Lauren I. R., Corry, David B., Kheradmand, Farrah, Atkinson, Mark A., Brakenridge, Scott C., Higuita, Nelson I. Agudelo, Metcalf, Jordan P., Hough, Catherine L., Messer, William B., Pulendran, Bali, Nadeau, Kari C., Davis, Mark M., Sesma, Ana Fernandez, Simon, Viviana, van Bakel, Harm, Kim-Schulze, Seunghee, Hafler, David A., Levy, Ofer, Kraft, Monica, Bime, Chris, Haddad, Elias K., Calfee, Carolyn S., Erle, David J., Langelier, Charles R., Eckalbar, Walter, Bosinger, Steven E., Peters, Bjoern, Kleinstein, Steven H., Reed, Elaine F., Augustine, Alison D., Diray-Arce, Joann, Maecker, Holden T., Altman, Matthew C., Montgomery, Ruth R., Becker, Patrice M., Rouphael, Nadine

“…Post-acute sequelae of SARS-CoV-2 (PASC) is a significant public health concern. We describe Patient Reported Outcomes (PROs) on 590 participants prospectively…”
Get full text

Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021 by Lewis, Nathaniel M, Naioti, Eric A, Self, Wesley H, Ginde, Adit A, Douin, David J, Keipp Talbot, H, Casey, Jonathan D, Mohr, Nicholas M, Zepeski, Anne, Gaglani, Manjusha, Ghamande, Shekhar A, McNeal, Tresa A, Shapiro, Nathan I, Gibbs, Kevin W, Clark Files, D, Hager, David N, Shehu, Arber, Prekker, Matthew E, Erickson, Heidi L, Gong, Michelle N, Mohamed, Amira, Henning, Daniel J, Steingrub, Jay S, Peltan, Ithan D, Brown, Samuel M, Martin, Emily T, Hubel, Kinsley, Hough, Catherine L, Busse, Laurence W, ten Lohuis, Caitlin C, Duggal, Abhijit, Wilson, Jennifer G, Gordon, Alexandra J, Qadir, Nida, Chang, Steven Y, Mallow, Christopher, Rivas, Carolina, Babcock, Hilary M, Kwon, Jennie H, Exline, Matthew C, Halasa, Natasha, Chappell, James D, Lauring, Adam S, Grijalva, Carlos G, Rice, Todd W, Rhoads, Jillian P, Stubblefield, William B, Baughman, Adrienne, Womack, Kelsey N, Lindsell, Christopher J, Hart, Kimberly W, Zhu, Yuwei, Schrag, Stephanie J, Kobayashi, Miwako, Verani, Jennifer R, Patel, Manish M, Tenforde, Mark W

“…Abstract Vaccine effectiveness (VE) against COVID-19 hospitalization was evaluated among immunocompetent adults (≥18 years) during March–August 2021 using a…”
Get full text

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021 by Tenforde, Mark W, Olson, Samantha M, Self, Wesley H, Talbot, H Keipp, Lindsell, Christopher J, Steingrub, Jay S, Shapiro, Nathan I, Ginde, Adit A, Douin, David J, Prekker, Matthew E, Brown, Samuel M, Peltan, Ithan D, Gong, Michelle N, Mohamed, Amira, Khan, Akram, Exline, Matthew C, Files, D Clark, Gibbs, Kevin W, Stubblefield, William B, Casey, Jonathan D, Rice, Todd W, Grijalva, Carlos G, Hager, David N, Shehu, Arber, Qadir, Nida, Chang, Steven Y, Wilson, Jennifer G, Gaglani, Manjusha, Murthy, Kempapura, Calhoun, Nicole, Monto, Arnold S, Martin, Emily T, Malani, Anurag, Zimmerman, Richard K, Silveira, Fernanda P, Middleton, Donald B, Zhu, Yuwei, Wyatt, Dayna, Stephenson, Meagan, Baughman, Adrienne, Womack, Kelsey N, Hart, Kimberly W, Kobayashi, Miwako, Verani, Jennifer R, Patel, Manish M

“…Adults aged ≥65 years are at increased risk for severe outcomes from COVID-19 and were identified as a priority group to receive the first COVID-19 vaccines…”
Get full text

IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition by Haslund-Gourley, Benjamin S., Woloszczuk, Kyra, Hou, Jintong, Connors, Jennifer, Cusimano, Gina, Bell, Mathew, Taramangalam, Bhavani, Fourati, Slim, Mege, Nathan, Bernui, Mariana, Altman, Matthew C., Krammer, Florian, van Bakel, Harm, Maecker, Holden T., Rouphael, Nadine, Diray-Arce, Joann, Wigdahl, Brian, Kutzler, Michele A., Cairns, Charles B., Haddad, Elias K., Comunale, Mary Ann

“…The glycosylation of IgG plays a critical role during human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, activating immune cells and…”
Get full text

Organization of Outpatient Care After COVID-19 Hospitalization by Peltan, Ithan D., Vranas, Kelly C., Mathews, Kusum S., Pinilla-Vera, Mayra, Rubins, David M., Arciniegas, Antonio, Riker, Richard, Elie, Marie-Carmelle, Shapiro, Nathan, Banner-Goodspeed, Valerie, Hibbert, Kathryn A., Brait, Kelsey, Jones, Alan, Galbraith, James, Nandi, Utsav, Peacock, Rebekah, Puskarich, Michael, Jones, Seth, Matthay, Michael, Kangelaris, Kirsten, Liu, Kathleen, Yee, Kimberly, Zhuo, Hanjing, Hendey, Gregory, Chang, Steven, Qadir, Nida, Beutler, Rebecca, Agarwal, Trisha, Wilson, Jennifer G., Vojnik, Rosemary, Pearson, Skyler J., Almasri, Eyad, Ginde, Adit, Howell, Michelle, Higgins, Carrie, Haukoos, Jason, Gravitz, Stephanie, Hiller, Terra, Goold, Audrey, Finigan, James, Kay, Stephen, McDonough, Kelli, Jayaprakash, Namita, Rivers, Emanuel P., Gill, Jasreen Kaur, Sherwin, Robert, Wooden, James, Mazzoco, Thomas, Gong, Michelle Ng, Amosu, Omowunmi, Hope, Aluko A., Nair, Rahul, Lopez, Brenda, Offor, Obiageli, Hypes, Cameron D., Salvagio, Elizabeth, Bime, Christian, Cristan, Elaine, Richardson, Lynne D., Goel, Neha, Maher, Patrick, Hite, Duncan, Hudock, Kristin, Arroyo, Jose Gomez, Roads, Tammy, Mireles-Cabodevila, Eduardo, Johnson, Nicholas J., Gundel, Stephanie, Evans, Laura, O'Mahony, D. Shane, Wallick, Julie A., Pedraza, Isabel, Krol, Olivia, Vranas, Kelly, Yealy, Donald M., Angus, Derek C., Weissman, Alexandra, Miller, Chadwick, Gibbs, Kevin, LaRose, Mary, Koehler, Lauren, Cassity, Evan, Mayer, Kirby, Mason, Jessica, Goodwin, Andrew, Grady, Abigail, Sturek, Jeffrey M., Grissom, Colin K., Hall, Grace L., Bouffler, Andrew, Walker, Erica, deBoisblanc, Bennett P., Lammi, Matthew R., Lauto, Paula, Rice, Todd W., Ringwood, Nancy, Nagrebetsky, Alexander, Fitzgerald, Laura, Reineck, Lora A., Bienstock, Karen

Get full text

Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study by Ozonoff, Al, Milliren, Carly E., Cairns, Charles B., Shaw, Albert C., van Bakel, Harm, Esserman, Denise A., Simon, Viviana, Bime, Christian, Haddad, Elias K., Pulendran, Bali, McComsey, Grace A., Augustine, Alison D., Ozonoff, Al, Schaenman, Joanna, Milliren, Carly E., Cairns, Charles B., Kraft, Monica, Sesma, Ana Fernandez, Erle, David J., Messer, William B., Higuita, Nelson I. Agudelo, Atkinson, Mark A., Brakenridge, Scott C., Ehrlich, Lauren I.R., Peters, Bjoern, Reed, Elaine F., McEnaney, Kerry, Lentucci, Claudia, Saluvan, Mehmet, Chang, Ana C., Shaheen, Tanzia, Kho, Alvin T., Patel, Ravi, Guan, Leying, Khalil, Zain, Fourati, Slim, Overton, James A., Salehi-Rad, Ramin, Kangelaris, Kirsten N., Kim, James N., Goonewardene, I. Michael, Smith, Cecilia M., Mosier, Jarrod, Kimura, Hiroki, Walsh, Stephen R., Dela Cruz, Charles, Farhadian, Shelli, Iwasaki, Akiko, Ahuja, Neera, Rogers, Angela J., Artandi, Maja, Drevets, Douglas A., Anderson, Matthew L., Guirgis, Faheem W., Busch, Johanna, Gandhi, Saurin, Mehta, Aneesh K., Khor, Bernard, Farrugia, Keith, Elashoff, David, Ramires-Sanchez, Estefania, Magyar, Clara E., Gonzalez, Ana, Jones, Norman, Lota, Raphael, Milush, Jeff, Altamirano, Luz Torres, Tietje-Ulrich, Gayelan, Bernui, Mariana, Rogowski, Brandon, Woloszczuk, Kyra, Bell, Mathew R., Hughes, Trina, Chaudhary, Omkar, Coppi, Andreas, Fournier, John, Vijayakumar, Pavithra, Wunder Jr, Elsio, Young, H. Patrick, Zhao, Yujiao, Eaker, Lily Q., Bermúdez-González, Maria C., Raskin, Ariel, Kleiner, Giulio, Do, Evan Do, Hagan, Thomas, Din, Hena Naz, Yang, Samuel, Brunton, Amanda, Booth, J. Leland, Moldawer, Lyle L., Nelson, Ebony, Gabriele, Gio, Hussaini, Laila, Hellmeister, Kieffer, Johnson, Brandi, Ciric, Caroline R., Hewitt, Lauren, Carter, Erin, Panganiban, Bernadine

“…Better understanding of the association between characteristics of patients hospitalized with coronavirus disease 2019 (COVID-19) and outcome is needed to…”
Get full text